Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision

James J. Hsieh, Valerie Le, Dengfeng Cao, Emily H. Cheng, Chad J. Creighton

Research output: Contribution to journalReview article

36 Scopus citations

Abstract

Over the past 20 years, classifications of kidney cancer have undergone major revisions based on morphological refinements and molecular characterizations. The 2016 WHO classification of renal tumors recognizes more than ten different renal cell carcinoma (RCC) subtypes. Furthermore, the marked inter- and intra-tumor heterogeneity of RCC is now well appreciated. Nevertheless, contemporary multi-omics studies of RCC, encompassing genomics, transcriptomics, proteomics, and metabolomics, not only highlight apparent diversity but also showcase and underline commonality. Here, we wish to provide an integrated perspective concerning the future ‘functional’ classification of renal cancer by bridging gaps among morphology, biology, multi-omics, and therapeutics. This review focuses on recent progress and elaborates the potential value of contemporary pan-omics approaches with a special emphasis on cancer genomics unveiled through next-generation sequencing technology, and how an integrated multi-omics approach might impact precision-based personalized kidney cancer care in the near future.

Original languageEnglish
Pages (from-to)525-537
Number of pages13
JournalJournal of Pathology
Volume244
Issue number5
DOIs
StatePublished - Apr 2018

Keywords

  • biomarkers
  • genomics
  • metabolomics
  • personalized medicine
  • precision therapeutics
  • proteomics
  • renal cell carcinoma
  • targeted therapy
  • transcriptomics

Fingerprint Dive into the research topics of 'Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision'. Together they form a unique fingerprint.

  • Cite this